Steve E. Krognes - 30 Nov 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John Saia, as attorney-in-fact for Steve Krognes
Issuer symbol
GH
Transactions as of
30 Nov 2025
Net transactions value
$0
Form type
4
Filing time
01 Dec 2025, 21:41:43 UTC
Previous filing
03 Nov 2025
Next filing
05 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Krognes Steve E. Director 3100 HANOVER STREET, PALO ALTO /s/ John Saia, as attorney-in-fact for Steve Krognes 01 Dec 2025 0001666236

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +155 +0.84% $0.000000 18,591 30 Nov 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -155 -13% $0.000000 1,080 30 Nov 2025 Common Stock 155 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a restricted stock unit award granted on August 9, 2022 that vested as to 25% of the shares subject to such award on June 30, 2023. The remaining 75% of the shares subject to such award vests in substantially equal installments on each monthly anniversary of June 30, 2023, during the three-year period thereafter.
F2 Not applicable for Restricted Stock Units.